NCT01781507View on ClinicalTrials.gov

Study of Bronchodilation Effects of Cetirizine

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Allergic RhinitisAsthma
Interventions
DRUG

Cetirizine

Cetirizine is an antihistamine currently indicated for allergic rhinitis

DRUG

Placebo

This placebo ( sugar pill) will provide the negative control for this study

Trial Locations (1)

90025

California Allergy and Asthma Medical Group, Los Angeles

All Listed Sponsors
collaborator

McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

INDUSTRY

lead

California Allergy and Asthma Medical Group, Inc.

OTHER

NCT01781507 - Study of Bronchodilation Effects of Cetirizine | Biotech Hunter | Biotech Hunter